With World Thrombosis Day just passed, we would like to look back over five publications, using #CellixTech, that have forwarded the world&#

In the last of our four part series with Dmitry Kashanin, we look at the work that has been done since Cellix took on the challenge of worki

In the third of our four part series with Dmitry Kashanin, we look into one of the biggest challenges facing the future of microfluidics - s

In the second of a four part series with Dmitry Kashanin, we look into the research and innovation that was being done behind the scenes in

Welcome to the first of a 4 part interview series with Dmitry Kashanin, the CTO of Cellix. In this article, we have a look towards the more

In another interview with Cellix CEO, Vivienne Williams, we cover the importance of university spin-outs and dealing with the challenges pre

I sat down again with our CEO, Vivienne William’s, to hear the story of Cellix from her perspective. The path from university start-up to su

Given many innovations in the area of cell analysis and sorting, there is now a multitude of different ways of analyzing and sorting cells.

I sat down recently with our CEO, Vivienne Williams, to ask what are Cellix’s plans for the future and why are we so excited for BIO Interna

Being an SME, especially one in the field of biotech, is about much more than just making a product and selling it. SMEs are an integral pa

“It's one thing to demo in a lab on how to do cell culture on your chip. It's another to give your chip to someone and tell them to

The SniffPhone, a device developed for the detection of disease from exhaled breath, has been awarded the 2018 Innovation Award from the...

In the second part of our 'Building a Biotech' series, our CEO Vivienne Williams reflects on her time at the European Commission workshop...

Our CEO Vivienne Williams talks about LES 2018 and why IP is important for Cellix, for biotech start-ups in general, and for industry, innov